1,041 material Form 8-K filings that 824 companies we cover made with the SEC in November 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
On November 2, 2025, Coeur Mining agreed to acquire New Gold through a plan of arrangement, with New Gold shareholders receiving 0.4959 Coeur shares for each New Gold share. The company said the deal implies $8.51 per New Gold share, a 16% premium to New Gold's October 31, 2025 NYSE American close, and a total equity value of about $7 billion. Coeur holders would own about 62% of the combined company and New Gold holders about 38%, so the deal would significantly change Coeur's share count and ownership, and it is subject to shareholder, court and regulatory approvals.
Exchange ratio of 0.4959 Coeur common shares per New Gold common share, implying $8.51 per share based on Coeur's October 31, 2025 NYSE closing price
Total equity value of about $7 billion for New Gold; pro forma combined equity market capitalization of about $20 billion
Coeur stockholders to own about 62% and New Gold shareholders about 38% of the combined company; two New Gold directors, including CEO Patrick Godin, to join Coeur's board
Expected to close in the first half of 2026; outside date May 15, 2026, extendable to August 15, 2026; termination fees of $414 million (Coeur) and $255 million (New Gold) in certain circumstances
Novanta reported third-quarter 2025 GAAP revenue of $247.8 million, up 1.4% from a year earlier, but GAAP net income fell to $10.7 million from $19.2 million and GAAP diluted EPS fell to $0.30 from $0.53. Adjusted diluted EPS rose to $0.87 from $0.85, while organic revenue declined 3.8%. The company expects fourth-quarter GAAP revenue of $253 million to $257 million and full-year 2025 GAAP revenue of $975 million to $979 million.
Q3 GAAP revenue was $247.8 million, up 1.4%; organic revenue growth was (3.8)%, with acquisitions adding 3.4% and currency adding 1.8%.
GAAP net income was $10.7 million, or $0.30 per diluted share, versus $19.2 million, or $0.53, a year earlier.
Adjusted diluted EPS was $0.87 versus $0.85; adjusted EBITDA was $58.1 million versus $57.0 million.
Q4 2025 guidance: GAAP revenue of $253 million to $257 million and adjusted diluted EPS of $0.87 to $0.93; full-year 2025 adjusted diluted EPS of $3.24 to $3.30.
Insperity reported third-quarter 2025 revenue up 4% to $1.6 billion, but a net loss of $20 million, or $(0.53) per diluted share, compared with net income of $3 million a year earlier, as gross profit fell 15% on higher-than-expected benefits costs. The company also amended its UnitedHealthcare medical coverage arrangement, extending it through 2028 with additional cost savings starting in 2026, and gave its full-year 2025 adjusted EPS guidance of $0.84 to $1.47.
Q3 2025 revenue rose 4% to $1.6 billion; gross profit fell 15% to $195 million
Q3 2025 net loss of $20 million; diluted EPS $(0.53) versus $0.07 in Q3 2024; adjusted EPS $(0.20)
UnitedHealthcare amendment extends the arrangement through 2028 and lets Insperity elect a claim cost limit of $500,000, $750,000, or $1,000,000 per participant per year
Q4 2025 adjusted EPS guidance is $(0.79) to $(0.16); full-year 2025 adjusted EPS guidance is $0.84 to $1.47
Centerspace reported third-quarter 2025 net income of $3.19 per diluted share, compared with a loss of $0.40 a year earlier, helped by a $79.5 million gain on real estate sales. Core FFO was $1.19 per diluted share, up from $1.18, but the company lowered its 2025 net income per share outlook to $1.97 to $2.19 from $2.50 to $2.76.
Q3 2025 net income of $3.19 per diluted share, versus a $0.40 loss in Q3 2024; results include a $79.5 million gain on sale of real estate.
Q3 2025 Core FFO of $1.19 per diluted share, up 0.8% from $1.18 a year earlier.
2025 net income per diluted share outlook cut to $1.97 to $2.19 from $2.50 to $2.76; Core FFO outlook narrowed to $4.88 to $4.96 from $4.88 to $5.00.
Same-store NOI rose 4.5% in Q3 2025 year over year; total liquidity was $200.4 million at September 30, 2025.
SBA Communications reported third-quarter 2025 results on November 3, 2025. Total revenues rose to $732.3 million from $667.6 million, but net income fell to $240.4 million from $255.9 million and diluted EPS fell to $2.20 from $2.40. The company also narrowed its full-year 2025 outlook, lowering the Adjusted EBITDA midpoint by $4.0 million on the timing of the Canada tower sale and Millicom site closings, and declared a $1.11 quarterly dividend.
Total revenues $732.3 million vs. $667.6 million a year earlier; site leasing revenue $656.4 million, up 4.9%
Net income $240.4 million vs. $255.9 million; diluted EPS $2.20 vs. $2.40
Full-year 2025 Adjusted EBITDA outlook $1,909 million to $1,919 million, $4.0 million lower at the midpoint than the August 4, 2025 outlook
Quarterly dividend of $1.11 per share, payable December 11, 2025 to holders of record on November 13, 2025
Corebridge Financial reported third quarter 2025 net income of $144 million, or $0.27 per share, compared with a loss of $1.2 billion a year earlier. Operating EPS fell to $0.96 from $1.23, and adjusted pre-tax operating income dropped 29% to $654 million, partly due to an annual actuarial assumption update. The company also said it is looking forward to welcoming its next CEO.
Net income was $144 million ($0.27 per share) versus a loss of $1.2 billion ($2.02 per share loss) in Q3 2024.
Operating EPS was $0.96 versus $1.23 a year earlier; adjusted pre-tax operating income was $654 million, down 29%.
Premiums and deposits rose 34% to $12.3 billion; the company returned $509 million to shareholders, including $381 million in share repurchases.
The board declared a quarterly dividend of $0.24 per share, payable December 31, 2025, to holders of record on December 17, 2025.
Williams reported third-quarter 2025 results with adjusted EBITDA of $1.920 billion, up 13% from a year earlier, and total revenues of $2.923 billion, up from $2.653 billion. GAAP net income available to common stockholders fell to $646 million, or $0.53 per diluted share, from $705 million, or $0.58, a year earlier, and the company reaffirmed its 2025 adjusted EBITDA guidance midpoint of $7.75 billion while raising its 2025 growth capital budget by $500 million.
Adjusted EBITDA was $1.920 billion, up $217 million or 13% from third quarter 2024; adjusted EPS was $0.49, up 14%.
GAAP net income was $646 million ($0.53 per diluted share), down from $705 million ($0.58) a year earlier, including a $25 million compression asset write-off.
Cash flow from operations rose 16% to $1.439 billion; AFFO rose 13% to $1.449 billion.
2025 adjusted EBITDA guidance midpoint of $7.75 billion was reaffirmed; 2025 growth capex was increased by $500 million to between $3.95 billion and $4.25 billion for the Louisiana LNG project with Woodside Energy.
CNO Financial Group reported third quarter 2025 net income of $23.1 million, or $0.24 per diluted share, up from $9.3 million, or $0.09, a year earlier, and total revenues of $1,188.7 million compared with $1,129.6 million. The results include a $96.7 million non-operating goodwill and other asset impairment tied to the Web Benefits Design and DirectPath acquisitions, and the company raised its run rate operating return on equity target by 50 basis points.
Net income was $23.1 million, or $0.24 per diluted share, versus $9.3 million, or $0.09, in 3Q24.
Net operating income was $127.2 million, or $1.29 per diluted share, versus $119.2 million, or $1.11, in 3Q24.
A $96.7 million non-operating charge covered goodwill and other asset impairment related to the 2019 and 2021 acquisitions of Web Benefits Design and DirectPath.
The operating ROE target was raised by 50 basis points, for 200 basis points of total improvement through 2027 from a 2024 run rate of 10%.
Tennant reported third quarter 2025 net sales of $303.3 million, down 4.0% from a year earlier, while GAAP net income fell 28.4% to $14.9 million. Adjusted diluted EPS rose 5.0% to $1.46, and the company reaffirmed its full-year net sales and Adjusted EBITDA ranges but now expects organic growth marginally below its prior range, with Adjusted EBITDA toward the low end of $196 million to $209 million.
Q3 net sales of $303.3 million fell 4.0%, with a 5.4% organic decline driven mainly by volume in the Americas.
GAAP diluted EPS was $0.80 versus $1.09, while adjusted diluted EPS was $1.46 versus $1.39.
Adjusted EBITDA rose 4.0% to $49.8 million, and the margin widened 120 basis points to 16.4%.
2025 guidance: net sales $1.210 billion to $1.250 billion reaffirmed; organic growth now projected marginally below the prior (1)% to (4)% range.
UFP Technologies reported third-quarter 2025 sales of $154.6 million, up 6.5%, while net income of $16.4 million and diluted EPS of $2.11 were flat with a year earlier. Higher costs, including about $3 million in incremental labor expense at its Illinois AJR facility, pushed gross margin down to 27.7% and operating income down 5.6%. Nine-month sales rose 26.0% to $453.9 million and diluted EPS rose to $6.52 from $5.49, though the filing gives no forward guidance.
Q3 2025 sales were $154.6 million, up 6.5% from $145.2 million; organic sales were essentially flat.
Q3 diluted EPS was $2.11, the same as Q3 2024; adjusted EPS was $2.39 versus $2.49.
Gross margin fell to 27.7% from 28.6%, and about $3 million in incremental labor cost was incurred at the AJR facility.
Nine-month net income was $50.7 million, or $6.52 per diluted share, versus $42.6 million, or $5.49, a year earlier.
IAC reported third-quarter 2025 revenue of $589.8 million, down 8% from $642.0 million a year earlier, and an operating loss of $20.4 million compared with operating income of $8.1 million. The net loss attributable to IAC shareholders narrowed to $21.9 million, or $0.27 per diluted share, from $243.7 million, helped by a $17.5 million unrealized gain on its MGM Resorts stake versus a $346.3 million loss a year earlier. Adjusted EBITDA fell 59% to $29.1 million, and the company set full-year 2025 outlook for People Inc. operating income of $180-$200 million and Adjusted EBITDA of $325-$340 million.
Revenue of $589.8 million fell 8%; People Inc. Digital revenue rose 9% to $269 million.
Operating loss of $20.4 million includes $21 million of legal fees and settlement expenses tied to a concluded legacy business litigation.
IAC repurchased 2.8 million shares for $100 million between August 6 and October 31, 2025, leaving 6.4 million shares in its authorization.
People Inc. signed a deal with Microsoft to help build its AI Publisher Content Marketplace and acquired Feedfeed on October 1, 2025.
Realty Income reported third-quarter 2025 net income available to common stockholders of $315.8 million, or $0.35 per share, up from $261.8 million, or $0.30 per share, a year earlier, on revenue of $1,470.6 million. The company narrowed its 2025 AFFO per share guidance to $4.25 to $4.27 and raised its investment volume guidance to approximately $5.5 billion, but lowered its net income per share guidance to $1.27 to $1.29 from $1.29 to $1.33.
Q3 2025 AFFO was $1.08 per diluted share, compared with $1.05 a year earlier; total revenue was $1,470.6 million, compared with $1,330.9 million.
2025 AFFO per share guidance was revised to $4.25 to $4.27, from $4.24 to $4.28 previously.
2025 net income per share guidance was revised to $1.27 to $1.29, from $1.29 to $1.33 previously.
2025 investment volume guidance was raised to approximately $5.5 billion, from approximately $5.0 billion previously.
Ichor reported third quarter 2025 revenue of $239.3 million, up from $211.1 million a year earlier but slightly below $240.3 million in the prior quarter, while its GAAP net loss widened to $22.9 million, or $(0.67) per diluted share. The company guided fourth quarter revenue to $210 million to $230 million, and management said the loss included a $16.7 million inventory impairment tied to a consolidation restructuring plan.
Q3 2025 revenue was $239.3 million, versus $240.3 million in Q2 2025 and $211.1 million in Q3 2024.
GAAP net loss was $22.9 million, or $(0.67) per diluted share, compared with a $9.4 million loss in Q2 2025.
Non-GAAP diluted EPS was $0.07; GAAP gross margin fell to 4.6% from 11.3% in Q2 2025.
Q4 2025 outlook: revenue of $210 million to $230 million (midpoint $220 million) and GAAP diluted EPS of $(0.33) to $(0.17).
Hims & Hers reported third quarter 2025 revenue of $599.0 million, up 49% from a year earlier, and Adjusted EBITDA of $78.4 million, up from $51.1 million. Net income fell to $15.8 million from $75.6 million, a year-earlier figure that included a $60.8 million tax benefit. The company narrowed its full-year 2025 revenue guidance to $2.335 billion to $2.355 billion and Adjusted EBITDA guidance to $307 million to $317 million.
Q3 2025 revenue was $599.0 million, up 49% from $401.6 million; subscribers reached 2,471 thousand, up 21%.
Q3 2025 net income was $15.8 million, compared with $75.6 million in Q3 2024, which included a $60.8 million tax benefit.
Q3 2025 Adjusted EBITDA was $78.4 million, up from $51.1 million; gross margin was 74%, down from 79%.
Full-year 2025 guidance was narrowed to $2.335 billion to $2.355 billion in revenue; Q4 2025 revenue guidance is $605 million to $625 million.
Sanmina reported unaudited fourth-quarter fiscal 2025 revenue of $2.1 billion, up from $2.0 billion a year earlier, and non-GAAP diluted EPS of $1.67, up from $1.43. GAAP diluted EPS fell to $0.88 from $1.09, and GAAP operating income was $78.5 million versus $89.6 million, with acquisition and integration charges of $27.1 million in the quarter. The company also guided first-quarter fiscal 2026 revenue to $2.9 billion to $3.2 billion and non-GAAP diluted EPS to $1.95 to $2.25.
Q4 revenue $2.1 billion versus $2.0 billion a year earlier; GAAP diluted EPS $0.88 versus $1.09
Non-GAAP diluted EPS $1.67 versus $1.43; GAAP operating margin 3.7% versus 4.4%
Fiscal 2025 revenue $8.1 billion; cash flow from operations $621 million; free cash flow $478 million
Q1 fiscal 2026 outlook: revenue $2.9 billion to $3.2 billion; non-GAAP diluted EPS $1.95 to $2.25
Viper Energy reported a third quarter 2025 net loss attributable to Viper of $77 million, or $0.52 per Class A share, compared with net income of $49 million in the third quarter of 2024. The loss was driven mainly by a $360 million non-cash impairment, while total operating income rose to $418 million from $211 million a year earlier. The company also agreed to sell its non-Permian assets for $670 million, expected to close in the first quarter of 2026, and declared a total base-plus-variable dividend of $0.58 per share.
Q3 2025 net loss attributable to Viper of $77 million, or $0.52 per Class A share, versus net income of $49 million in Q3 2024
Q3 2025 pro forma cash available for distribution of $165 million, or $0.97 per Class A share
Declared Q3 2025 base dividend of $0.33 and variable dividend of $0.25 per Class A share, payable November 20, 2025
Agreed to sell non-Permian assets for $670 million, with closing expected in Q1 2026
Inspire Medical Systems reported third-quarter 2025 revenue of $224.5 million, up 10%, but net income fell to $9.9 million from $18.5 million, and diluted EPS was $0.34 versus $0.60 a year earlier. The company raised its full-year 2025 diluted EPS guidance to $0.90 to $1.00 from $0.40 to $0.50 while maintaining full-year revenue guidance of $900 million to $910 million.
Q3 revenue was $224.5 million, up 10% from $203.2 million; U.S. revenue was $214.4 million, up 9%.
Net income was $9.9 million versus $18.5 million, and diluted EPS was $0.34 versus $0.60 a year earlier.
Full-year 2025 diluted EPS guidance raised to $0.90 to $1.00 from $0.40 to $0.50; revenue guidance maintained at $900 million to $910 million.
Operating expenses rose 17% to $183.1 million, and cash, cash equivalents and investments were $410.9 million at September 30, 2025.
Tompkins Financial sold its subsidiary Tompkins Insurance Agencies to Arthur J. Gallagher & Co. for about $223 million in cash, subject to customary adjustments, and its press release says the sale closed with a pre-tax gain of $183 million. The same day, the company sold $565.0 million of debt securities at a pre-tax loss of about $79.5 million and reinvested the proceeds at an estimated higher yield, so the net effect on results depends on both moves.
Sale price of about $223 million in cash to Gallagher, announced in an agreement dated October 31, 2025 and closed by November 3, 2025 per the press release.
Press release states a pre-tax gain of $183 million on the sale.
On November 3, 2025, the company sold $565.0 million of debt securities with a 1.56% average book yield, a pre-tax loss of about $79.5 million, and reinvested at an estimated 4.52% average book yield.
Gallagher's post-closing indemnification recourse is capped at $557,500, and the company and its affiliates agreed to a five-year non-compete with limited exceptions.
Pinnacle West reported third-quarter 2025 net income attributable to common shareholders of $413.2 million, or $3.39 per diluted share, up from $3.37 a year earlier, on operating revenues of $1.82 billion. The company raised its 2025 earnings guidance to $4.90-$5.10 per diluted share, citing customer and sales growth and weather, partly offset by higher operations and maintenance expenses, and gave a 2026 range of $4.55-$4.75.
Q3 2025 net income attributable to common shareholders was $413.2 million, or $3.39 per diluted share, versus $395.0 million, or $3.37, in Q3 2024.
Nine-month 2025 diluted EPS was $4.93, compared with $5.32 in the first nine months of 2024, and the company said year-to-date earnings were 2.4% lower.
2025 EPS guidance was raised to $4.90-$5.10; 2026 EPS guidance is $4.55-$4.75 on a weather-normalized basis.
APS plans to invest more than $2.5 billion annually through 2028 and will grant an additional $3 million in shareholder funds for utility bill assistance and related programs.
onsemi reported third-quarter 2025 revenue of $1,550.9 million and diluted earnings per share of $0.63, both up from the prior quarter but down from a year earlier. It also gave a fourth-quarter 2025 revenue outlook of $1,480 million to $1,580 million, and its nine-month results include a GAAP net loss of $60.8 million tied to large restructuring and impairment charges.
Q3 revenue of $1,550.9 million was up 6% from $1,468.7 million in Q2 2025 but down 12% from $1,761.9 million in Q3 2024.
Diluted EPS was $0.63 on both a GAAP and non-GAAP basis, versus $0.41 GAAP in Q2 2025 and $0.93 GAAP in Q3 2024.
Nine-month GAAP net loss attributable to the company was $60.8 million, including $608.1 million of restructuring, asset impairments and other charges, net.
Q4 2025 outlook: revenue of $1,480 million to $1,580 million and non-GAAP diluted EPS of $0.57 to $0.67.
Kimberly-Clark agreed to acquire Kenvue in a deal that values Kenvue at an enterprise value of approximately $48.7 billion. Kenvue shareholders would receive $3.50 in cash and 0.14625 Kimberly-Clark shares per Kenvue share, or $21.01 per share based on the October 31, 2025 closing price. Upon closing, Kimberly-Clark shareholders are expected to own about 54% of the combined company, and the transaction is expected to close in the second half of 2026 subject to shareholder, regulatory and other approvals.
Kenvue shareholders receive $3.50 in cash plus 0.14625 Kimberly-Clark shares per share, a total of $21.01 per share based on the October 31, 2025 closing price
Current Kimberly-Clark shareholders are expected to own about 54% of the combined company; Kenvue shareholders about 46%
Companies expect $2.1 billion in run-rate synergies, net of reinvestment, and the cash component will be funded partly by new debt and the sale of a 51% interest in the IFP business
Expected closing in the second half of 2026; the outside date is November 2, 2026, with a possible extension to May 3, 2027
Pediatrix Medical Group reported third-quarter 2025 net income of $71.7 million, or $0.84 per diluted share, up from $19.4 million, or $0.23, a year earlier. Net revenue fell to $492.9 million from $511.2 million, which the company attributed mainly to practice dispositions. The company raised its full-year 2025 Adjusted EBITDA outlook to a range of $270 million to $290 million.
Q3 2025 net revenue $492.9 million vs. $511.2 million a year earlier; same-unit net revenue grew 8.0 percent
Q3 2025 Adjusted EBITDA $87.3 million vs. $60.2 million; Adjusted EPS $0.67 vs. $0.44
Full-year 2025 Adjusted EBITDA now expected at $270 million to $290 million
Cash and cash equivalents $340.1 million at September 30, 2025; total debt $602 million
SM Energy reported third-quarter 2025 results on November 3, 2025. Net income fell to $155.1 million, or $1.35 per diluted share, from $240.5 million, or $2.09, a year earlier, while total operating revenues and other income rose to $811.6 million from $643.6 million. The company raised its full-year 2025 capital expenditure guidance to $1.375 billion to $1.395 billion, though it lowered several cost estimates and narrowed production guidance.
Third-quarter net income was $155.1 million, or $1.35 per diluted share, versus $240.5 million, or $2.09, in the same period of 2024.
Total operating revenues and other income were $811.6 million, compared with $643.6 million in the third quarter of 2024.
Full-year 2025 capital expenditure guidance was increased to $1.375 billion to $1.395 billion, excluding acquisitions.
Adjusted free cash flow was $234.3 million, an 80% increase from the same period in 2024.
Freshpet reported third-quarter 2025 net sales of $288.8 million, up 14.0% from a year earlier, and net income of $101.7 million, which includes a $77.9 million tax benefit from releasing a valuation allowance. The company narrowed its full-year 2025 net sales growth outlook to about 13% and cut its Adjusted EBITDA range to $190 million to $195 million from $190 million to $210 million, while lowering its capital expenditure plan to about $140 million from about $175 million. Shareholders get higher sales but a lower top end for profit guidance, and the reported net income gain depends on a one-time tax item.
Q3 net sales rose 14.0% to $288.8 million; Q3 Adjusted EBITDA was $54.6 million versus $43.5 million a year earlier
Q3 net income of $101.7 million includes a discrete $77.9 million tax benefit; Q3 gross margin was 39.5% versus 40.4%
2025 Adjusted EBITDA guidance is $190 million to $195 million, versus $190 million to $210 million previously
2025 capital expenditure guidance is about $140 million, down from about $175 million; the company expects to be free cash flow positive for 2025
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.